A quick test for diagnosing sexually transmitted infections using a swab sample.
Official title: STI NG Plus, a Swab to Answer Molecular Panel Test for Point of Care Diagnosis and Treatment Recommendation
Funded at Amplifidx INC · NIH-10832974 · Data updated 2026-11-12
This study is working on a quick and easy test that can tell you if you have a sexually transmitted infection (STI) using just a simple swab, giving you lab-quality results in about 30 minutes to help you get the care you need faster and with less hassle.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Amplifidx INC NIH-funded |
| Lab location | 1 site (Charlestown, United States) |
| Project start | May 1, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $293,189 |
| NIH project number | 5R43AI174562-02 |
| Project ID | NIH-10832974 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who are at risk for STIs or those who have symptoms suggestive of an STI.
✕Less likely to help
Patients who are not at risk for STIs or who have already been diagnosed and treated for their infections may not benefit from this research.
What this research studies
This research focuses on developing a rapid point-of-care test for diagnosing sexually transmitted infections (STIs) using a simple swab sample. The test aims to provide lab-quality results in as little as 30 minutes, which can significantly improve the diagnosis and treatment rates for STIs. By utilizing a molecular testing platform, the approach seeks to address the challenges of undiagnosed infections and the stigma associated with STIs, ultimately enhancing patient care and reducing complications such as infertility. The test is designed to be user-friendly, requiring minimal handling and no complex procedures.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of STIs, improving treatment outcomes and reducing the risk of serious health complications.
How similar studies have gone: Other research has shown success with similar point-of-care testing approaches for infectious diseases, indicating a promising avenue for this type of diagnostic technology.
Where this research is happening
-
Amplifidx INC
Charlestown, United States Active
Researchers
- Principal investigator: Dong, Shoulian — Amplifidx INC
- Study coordinator: Dong, Shoulian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.